TFAP2A and retinoblastoma: In this context, recent studies have further validated Transcription Factor Activating Enhancer-Binding Protein 2 Alpha (TFAP2A) promoter methylation as a highly specific biomarker in aqueous humor (92.7% diagnostic accuracy) for distinguishing retinoblastoma from benign retinal conditions [29,85,86].